Sort
82,697 grants matching “vaccine development”
IMMUNOBIOLOGY OF VARICELLA AND ZOSTER IN A PRIMATE MODEL
$867,251Ravi Mahalingam · University Of Colorado Denver · P01 · FY2014 · AG
NIH: Spatial Models of Intrahepatic Hepatitis Virus Propagation in Humans
$867,166Ruy M Ribeiro · Triad National Security, Llc · R01 · FY2025 · AI
Excellence in Research - Numerical and experimental investigations of droplet deposition in nasal cavity from topical intranasal corticosteroid sprays among diverse groups
$867,163Zheng Li · Morgan State University · · FY2024 · ENG
Fusion peptide directed immunogens that elicit neutralizing and protective antibodies in non-human primates
$867,163Andrew Barrett Ward · Scripps Research Institute, The · R01 · FY2024 · AI
Viral Genomics: evolution, spread, and host interactions
$867,120Pardis Christine Sabeti · Broad Institute, Inc. · U19 · FY2017 · AI
An Env apex-focused HIV-1 vaccine strategy
$867,099Michael R. Farzan · Boston Children'S Hospital · R01 · FY2025 · AI
Design of inhibitors targeted to the CD4 binding site on HIV-1 gp120
$867,084Asim K Debnath · New York Blood Center · R01 · FY2019 · AI
The Functional Significance of CTL Escape
$867,038University Of Wisconsin Madison · R01 · FY2005 · AI
Risk of Neonatal Vaccination for HIV/SIV Exposed Infants
$867,023Donald L Sodora · Seattle Biomedical Research Institute · R01 · FY2016 · DE
Host-Directed Therapy to Augment anti-M. tuberculosis Responses in the Setting of HIV Co-infection and to Sterilize the Tuberculoma
$866,688Smriti Mehra · Tulane University Of Louisiana · R01 · FY2018 · AI
Administrative Core
$866,429Cynthia Nau Cornelissen · Georgia State University · U19 · FY2023 · AI
Chromatin infrastructure of the Igh locus and its influence on VH gene usage
$866,303Amy L. Kenter · University Of Illinois At Chicago · R01 · FY2016 · AI
Elicitation of HIV Broadly Neutralizing Antibodies from Engineered B cells
$866,189James Even Voss · Scripps Research Institute, The · R01 · FY2024 · AI
UAB Center for AIDS Research
$866,171Michael S. Saag · University Of Alabama At Birmingham · P30 · FY2008 · AI
International Collaborations in Infectious Disease Research (ICIDR) (U01)
$866,151Matthew Lester Boulton · University Of Michigan At Ann Arbor · U01 · FY2012 · AI
Administrative Core
$866,150James Alasdair McIntyre · Wits Health Consortium (Pty), Ltd · U19 · FY2009 · AI
HIV-1 vaccine design emphasizing bnAb targets on membrane Env liposomes
$866,147Michael B Zwick · Scripps Research Institute, The · R01 · FY2020 · AI
HIV-1 vaccine design emphasizing bnAb targets on membrane Env liposomes
$866,147Michael B Zwick · Scripps Research Institute, The · R01 · FY2021 · AI
University of Rochester Vaccine and Treatment Evaluation Unit (VTEU)
$865,920Ann R Falsey · University Of Rochester · UM1 · FY2025 · AI
A versatile structure-based therapeutic platform for development of VHH-based antitoxin and antiviral agents
$865,682Charles Bix Shoemaker · Tufts University Boston · R01 · FY2023 · AI
Project 3: Anti-HIV/SHIV Efficacy of Combination Antiretroviral Intravaginal Ring
$865,518Richard B Pyles · Oak Crest Institute Of Science · U19 · FY2014 · AI
Eritoran (E5564), a TLR4 antagonist, as a novel therapeutic for influenza
$865,457Stefanie N. Vogel · University Of Maryland Baltimore · R01 · FY2015 · AI
Eritoran (E5564), a TLR4 antagonist, as a novel therapeutic for influenza
$865,457Stefanie N. Vogel · University Of Maryland Baltimore · R01 · FY2016 · AI
Generation of Genotypically Diverse R5 SHIVs as Tools in HIV-1 Vaccine Research
$865,415Cecilia C Cheng-Mayer · Aaron Diamond Aids Research Center · R24 · FY2015 · AI
Regulation of primary and secondary CD4 and CD8 T cell memory
$865,408John T. Harty · University Of Iowa · R37 · FY2017 · AI